Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Archive for April 6th, 2020
Law Bytes
Episode 200: Colin Bennett on the EU’s Surprising Adequacy Finding on Canadian Privacy Law
byMichael Geist
April 22, 2024
Michael Geist
April 15, 2024
Michael Geist
April 8, 2024
Michael Geist
March 25, 2024
Michael Geist
March 18, 2024
Michael Geist
Search Results placeholder
Recent Posts
- The Law Bytes Podcast, Episode 200: Colin Bennett on the EU’s Surprising Adequacy Finding on Canadian Privacy Law
- Debating the Online Harms Act: Insights from Two Recent Panels on Bill C-63
- The Law Bytes Podcast, Episode 199: Boris Bytensky on the Criminal Code Reforms in the Online Harms Act
- AI Spending is Not an AI Strategy: Why the Government’s Artificial Intelligence Plan Avoids the Hard Governance Questions
- The Law Bytes Podcast, Episode 198: Richard Moon on the Return of the Section 13 Hate Speech Provision in the Online Harms Act